4.50
(b) Minimum Liquidity
Minimum Liquidity of the Group shall be at least USD 5,000,000.
13.5.2 The Issuer undertakes to comply with the financial covenants in Clause 13.5.1 at all times, such compliance to be measured quarterly and certified by the Issuer with each quarterly and annual financial statement.
13.5.3 Equity Cure
If the Issuer fails (or would otherwise fail) to comply with any of the financial covenants in Clause 13.5.1, and within 15 Business Days of becoming aware of such breach, the Issuer receives net cash proceeds through any new Shareholder Injections (a "C ure Amount''), then such financial covenant shall be recalculated giving effect to the following pro forma adjustments:
For the purpose of measuring (i) the Gearing Ratio, Net Interest Bearing Debt as at the end o f the Relevant Period shall be decreased by an amount equal to the Cure Amount and (ii) the Liquidity, die Liquidity as at the end o f the Relevant Period shall be increased by an amount equal to the Cure Amount.
If, after giving effect to the foregoing recalculations, the Issuer is in compliance with all the financial covenants in Clause 13.5.1, the Issuer shall be deemed to have satisfied the requirements of the financial covenants as of the relevant original date
22
